Introduction
============

Psoriasis is a chronic and debilitating skin disease that results in adverse psychological, social and economic problems in individuals and society that characterized by raised, sensitive painful, disfiguring, itchy and erythematous lesions, appearing on any part of the body ([@B1]--[@B4]). The disease affects 2--3% of the worldwide population ([@B5], [@B6]) and given the nature of chronic, recurrent, and incurable enormous costs imposed on communities. In the United States, the annual cost of psoriasis was estimated between 112 to 135 billion dollars in 2013 and indirect cost of work absenteeism due to psoriasis was estimated 23.9 to 35.4 billion dollars ([@B7]). Psoriasis negatively affects ability to work because limits physical activity and in parallel with increasing severity of the disease significant disability will develop in the performance of patients. These problems can be more with psoriatic arthritis and joint symptoms ([@B8]--[@B11]). Due to the importance of work in people\'s lives, attention to the relationship between the disease and jobs and the interaction between these two issues was essential.

Sickness absence is undesirable consequences of work dysfunction. Sickness absence could impair productivity and led to feelings of frustration and fear of losing job ([@B12]). Due to negative impacts on labor productivity, cumbersome costs and interference with production quality, sickness absence from work has attracted more attention in recent years and has become an important issue in societies ([@B13]--[@B16]). According to the National Psoriasis Association of America, annually 56 million work hours are lost by patients with psoriasis ([@B17]). Sickness absence is a complex situation and has a multi-factorial etiology and many of these factors are controllable and preventable ([@B18], [@B19]).

In studies conducted in the absence from work, psoriasis was considered as a subgroup of all skin disorders and to date, the association of psoriasis sickness absence was not been independently investigated. The highest rate of absenteeism has been related to dermatitis ([@B20]).

The aim of this study was to assess the prevalence of absenteeism in patient s with psoriasis (as a chronic and debilitating disease) and determine the factors influencing the incidence of absenteeism in these patients.

Materials and Methods
=====================

Study design and population
---------------------------

A cross-sectional study from December 2012 to November of 2013 was conducted on patients with psoriasis. All samples were selected from patients with psoriasis who had referred to the Dermatology Clinic of Imam Khomeini Hospital in Tehran, Iran. This clinic is under coverage of Skin and Stem Cell Research Center of Tehran University of Medical Sciences. A trained health staff call phones to those were registered in the computer system of the clinic and after presenting the project, invite them to the participation in the study (Participation in this study was voluntary). Inclusion criteria were considered to have at least one year of employment. Unemployed people, pensioners, and housewives were excluded from the study.

Ethical Approval
----------------

Before entering the study, all participants signed a written consent form. In addition, they could exit the study at any time they wanted. This study was approved by the Ethics Committee of Tehran University of Medical Sciences.

Data collection
---------------

Data collection tool was a questionnaire consists of 6 main sections. Patients had to fill out the questionnaire under the supervision of the trained health staff. The information was collected by questionnaire included the following sections:

**A**) Socio-demographic characteristics such as gender, age, marital status; **B**) Lifestyle, including smoking (number of years and the number of cigarettes per day), height and weight which were used to calculate BMI and classifying patient in three groups: normal group BMI\< 25, overweight, 25 ≤BMI \<30 and obese BMI≥ 30 ([@B21]) ; **C**) Information about psoriasis included duration of the disease, type of the disease, area of involvement, joint problems and receiving phototherapy; **D**) Employment profile including: Job title; under which the two groups of patients in office work (White collar) and Non-office work (Blue collar) were classified, work schedule (day and night), the exposure to physical factors in the work environment (cold, vibration, trauma to the skin and nails, repeated friction). The exposure to chemical agents in the workplace especially for organic solvents, 3-chloro ethylene, acids, alkali, and paints considered as the chemical exposure. **E**) Relationship between employment and disease: disease exacerbation at work, decrease symptoms during vacations and leave, creating more job problem because of psoriasis, developing disability to perform the duties because of the disease; **F**) The number day of absence from work due to psoriasis in the last year. The absence of 7 days has been considered as short-term and more than 7 days has been considered as long-term.

SAPASI Questionnaire
--------------------

To determine the severity of psoriasis the Self-administered psoriasis area and severity index (SAPASI) was applied. In numerous of articles the validity and reliability of this index has been confirmed ([@B22]--[@B24]). SAPASI is simplified form of PASI, which should be filled out by the patient. The involved areas on a patient's body are shown by the shadow on a visual analog scale in this method. The severity of psoriasis based on the score obtained in the questionnaire is determined. The mild disease is the engagement of less than 10 of total body skin and the moderate to severe disease is the score of more than 10 ([@B25]).

Statistical analysis
--------------------

To determine the significance of correlation of the qualitative outcome including sickness absence with psoriasis the chi-square test was used. Finally, to control the confounding factors, binary logistic regression was applied. In all tests, the significance level of 0.05 and 95% CI (confidence interval) were considered. Data were analyzed with SPSS version 16 (Chicago, IL, USA).

Results
=======

For 202 patients with psoriasis the questionnaire was filled out. Ten questionnaires were excluded because of incomplete data and finally 192 questionnaires were analyzed.

The average age of the sample was 36.19 ± 11.86 SD and distribution of people in different age groups were roughly equal .The mean BMI in the samples was 25.92 ± 4.20 SD. Frequency distribution of Socio-demographic, lifestyle, disease Characteristics and other variables are showed in [Table 1](#T1){ref-type="table"}. 78.07% (n = 146) of all patients had no absences due to psoriasis and history of absent in 21.92% (n = 41) of patients were positive.

###### Frequency distribution of variables in all samples

  **Variables**                            **Numbers**   **%**
  ---------------------------------------- ------------- -------
  **Age**                                                
    20--30y                                71            37
    31--40y                                61            31.8
    \>40y                                  60            31.3
  **Sex**                                                
    Male                                   112           58.3
    Female                                 80            41.7
  **Marital status**                                     
    Married                                126           65.6
    Single                                 66            34.4
  **BMI**                                                
    \< 25,                                 80            41.7
    25 ≤ \<30                              83            43.2
    ≥ 30                                   29            15.1
  **Smoking**                                            
    Yes                                    63            32.8
    No                                     129           67.2
  **Duration of disease**                                
    \<10y                                  100           52.1
    10--20y                                58            30.2
    \>20y                                  34            17.7
  **Disease type**                                       
    plaque                                 173           90.1
    non-plaque                             19            9.9
  **Affected area**                                      
    scalp                                  52            27.1
    trunk                                  71            37
    upper limb                             66            34.4
    lower limb                             57            29.7
    Palms and soles                        134           69.8
  **Joint problems**                                     
    Yes                                    68            35.4
    No                                     124           64.6
  **Radiation therapy**                                  
    Yes                                    48            25
    No                                     144           75
  **Occupational groups**                                
    Office                                 109           56.8
    Non office                             83            43.2
  **Chemical exposure at work**                          
    Yes                                    30            15.6
    No                                     162           84.4
  **Physical exposure at work**                          
    Yes                                    59            30.7
    No                                     133           69.3
  **Exacerbations at work**                              
    Yes                                    74            38.5
    No                                     118           61.5
  **Disability in work**                                 
    Yes                                    90            46.9
    No                                     102           53.1
  **Problem on the employment**                          
    Yes                                    44            22.9
    No                                     148           77.1
  **Severity of disease (SAPASI score)**   131           68.2
    Mild (≤10)                             61            31.8
    Moderate to Sever (\>10)                             

The average numbers of days of absence were 10.25 and the duration of absence from work in 48.7% were long-term ≥7 days. 51.3% had short-term absence (\< 7 days). \[5 people that were unable to continue their work were excluded from the calculation of absence\].

Chi-square and regression results were showed in tables. Patients with severe to moderately severe disease (score\>10) in comparison to the patients with mild severity of disease (score \<10), had more sickness absence with *P*-value = 0.024. The relationship between radiation therapy with *P-*value= 0.002, palm and sole involvement with *P-*value \<0.001 and the absence was significant. Other variables such as disease duration and itching had not correlation to the incidence of absenteeism ([Table 2](#T2){ref-type="table"}). In regression analysis in the final multivariate model, only palm and sole involvement \[OR=3.56 (95%CI=1.26 -- 6.15), *P*\<0.001\] remained significant after adjusted for Confounding factors ([Table 3](#T3){ref-type="table"}). Among the occupational factors, chemical exposure (*P*-value \<0.001) and physical exposure (*P*-value= 0.005) were significantly correlated with the incidence of absenteeism.

###### Chi-square test results for disease risk factors of sickness absence in patients

  **Variables**                            **With Sickness absence n (%)**   **Without Sickness absence n (%)**   ***P*-value**
  ---------------------------------------- --------------------------------- ------------------------------------ ---------------------
  **Severity of disease (SAPASI score)**                                                                          
    Mild (≤10)                             22 (53.7)                         109 (72.2)                           **^\*^0.024**
    Moderate to Sever (\>10)               19 (46.3)                         42 (27.8)                            
  **Duration of illness**                                                                                         
    \<10y                                  19 (46.3)                         81 (53.6)                            0.69
    10--20y                                14 (34.1)                         44 (29.1)                            
    \>20y                                  8 (19.5)                          26 (17.2)                            
  **Severity of itch**                                                                                            
    Low                                    29 (70.7)                         108 (71.4)                           0.92
    High                                   12 (29.3)                         43 (28.5)                            
  **Palms and soles involvement**                                                                                 
    Yes                                    22 (53.7)                         36 (23.8)                            **^\*\*^0\<0.001**
    No                                     19 (46.3)                         115 (76.2)                           
  **Joint problems**                                                                                              
    Yes                                    21 (51.2)                         47 (31.1)                            **^\*\*\*^0.017**
    No                                     20 (48.8)                         104 (68.9)                           
  **Radiation therapy**                                                                                           
    Yes                                    18 (43.9)                         30 (19.9)                            **^\*\*\*\*^0.002**
    No                                     23 (56.1)                         121 (80.1)                           

###### Logistic regression results for disease risk factors of sickness absence in patients

  **Variables**                            **Odds ratio**   **95%CI**    **P-value**
  ---------------------------------------- ---------------- ------------ --------------
  **Severity of disease (SAPASI score)**                                 
    Mild (≤10)                             1                             
    Moderate to Sever (\>10)               1.76             0.82--3.78   **0.56**
  **Joint problems**                                                     
    No                                     1                             
    Yes                                    1.62             0.76--3.46   **0.21**
  **Palms and soles involvement**                                        
    No                                     1                             
    Yes                                    3.56             1.67--7.58   **0\<0.001**
  **Radiation therapy**                                                  
    No                                     1                             
    Yes                                    2.79             1.26--6.15   **0.37**

Absenteeism in patients with psoriasis who were exposed to chemical and physical factors than to the patients who are not exposed to these factors was significant. Patients with occupational disability due to the disease (with a p-value \<0.001) and patients who had trouble for following their earlier work had more absence (*P*-value \<0.001) ([Table 4](#T4){ref-type="table"}).

###### Chi-square test results for job risk factors of sickness absence in psoriasis patients

  **Variables**                   **With Sickness absence n (%)**   **Without Sickness absence n (%)**   ***P*-value**
  ------------------------------- --------------------------------- ------------------------------------ -----------------
  **Occupational groups**                                                                                
    Office                        17 (41.5)                         92 (60.9)                            
    Non office                    24 (58.5)                         59 (39.1)                            **^\*^0.026**
  **Work schedule**                                                                                      
    Day work                      34 (82.9)                         140 (92.7)                           0.057
    Shift work                    7 (17.1)                          11 (7.3)                             
  **Chemical exposure at work**                                                                          
    Yes                           13 (31.7)                         17 (11.3)                            **^\*^\<0.001**
    No                            28 (68.3)                         134 (88.7)                           
  **Physical exposure at work**                                                                          
    Yes                           20 (48.8)                         39 (25.8)                            **^\*^0.005**
    No                            21 (51.2)                         112 (74.2)                           
  **Exacerbations at work**                                                                              
    Yes                           24 (58.5)                         50 (33.1)                            **^\*^0.003**
    No                            17 (41.5)                         101 (66.9)                           
  **Disability in work**                                                                                 
    Yes                           29 (70.7)                         61 (40.4)                            **^\*^\<0.001**
    No                            12 (29.3)                         90 (59.6)                            
  **Problem on the employment**                                                                          
    Yes                           24 (58.5)                         20 (13.2)                            **^\*^\<0.001**
    No                            17 (41.5)                         131 (86.8)                           

In regression analysis in the final multivariate model, chemical exposure \[OR=2.65 (95%CI=1.01--7.08), *P*\<0.001\] and creating problem on work task \[OR=6.08 (95%CI=2.46 -- 15.07), *P*\<0.001\] remained significant after adjusted for Confounding factors ([Table 5](#T5){ref-type="table"}).

###### Logistic regression results for job risk factors of sickness absence in psoriasis patients

  **Variables**                   **Odds ratio**   **95%CI**     ***P*-value**
  ------------------------------- ---------------- ------------- -----------------
  **Occupational groups**                                        
    Office                        1                              
    Non office                    1.10             0.44--2.77    0.82
  **Work schedule**                                              
    Day work                      1                              
    Shift work                    1.49             0.44--5.03    0.52
  **Chemical exposure at work**                                  
    No                            1                              
    Yes                           2.65             1.01--7.08    **^\*^0.05**
  **Physical exposure at work**                                  
    No                            1                              
    Yes                           1.53             0.58--4.03    0.38
  **Exacerbations at work**                                      
    No                            1                              
    Yes                           1.90             0.84--4.32    0.12
  **Disability in work**                                         
    No                            1                              
    Yes                           1.54             0.61--3.88    0.36
  **Problem on the employment**                                  
    No                            1                              
    Yes                           6.08             2.46--15.07   **^\*^\<0.001**

Discussion
==========

This study was accomplished to assess the impact of the disease on sickness absence (as a result of work dysfunction). The main purpose of this study was to determine factors associated with the development of sickness absence due to psoriasis and occupational.

In this study, 21.4% of patients with psoriasis had absenteeism due to illness, and the average number of days absent was 10.25 days. In a study on construction workers, the average days of dermatosis (all type of disorder) sickness absence was 53 days ([@B26]). In our study, 48.7% of patients had long-term absence (≥7 days), which is noticeable. Dermatitis was responsible for long periods of absence with average of 10 days ([@B20]). The period of absence caused by occupational dermatologic disorders was long and often more than two weeks ([@B26]).

Attention to this issue is very important because the consequences of short and long-term period of absences are different. The long-term sickness absence leads to increased social and economic costs and in addition to the negative impact on the professional and personal lives, increasing the risk of long-term disability ([@B27]--[@B29]).

Disease severity (based on SAPASI score) was the most important factor associated with psoriasis and showed a significant relationship with the occurrence of absenteeism; moderate to severe disease were accompanied with a greater incidence of absenteeism. More severe disease (high SAPASI or PASI score) indicate extensive skin involvement. These patients need care that is more complex and perhaps more phototherapy sessions, frequent medical visits and even more hospitalizations and as a result, lead to an increase in loss of workdays and increased burden of psoriasis disease on society.

Palm and sole involvement and joint problem cause more absence in patients with psoriasis. Psoriatic arthropathy can affect mobility and the pain can increase sickness absence ([@B30]).

This research is the first study to investigate occupational factors in patients with psoriasis but has some limitations. Because of the cross-sectional nature of the study, identifying the causal relationship between risk factors and sickness absence was not possible and a large number of patients because of unwillingness to participate in the study as well as exclusion criteria were excluded from the study. The absence was asked from patients with a question; therefore, there is possibility of recall bias.

Conclusion
==========

Psoriasis with its chronic and recurrence nature especially in higher severities causes disabilities that deeply affect Work performance and can decrease the efficiency. The most important adverse occupational consequence was increased absenteeism in these patients, which increases the burden of disease and increase undesirable effect on patient and society. The results of this study can demonstrate the importance of taking into account the occupational factors in the management of psoriasis patients by physicians. Further studies in this area were recommended.
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